![Michael Baker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 351 933 $ in data 31/08/2026
Dr. Michael Baker is a Chief Executive Officer & Managing Director at Percheron Therapeutics Ltd. and an Investment Associate at Bioscience Managers Pty Ltd. He is on the Board of Directors at Radiopharm Theranostics (USA), Inc. Dr. Baker was previously employed as an Independent Non-Executive Director by Radiopharm Theranostics Ltd., a Chief Executive Officer, MD & Director by Arovella Therapeutics Ltd., and a Senior Manager by Hexima Ltd. He received his undergraduate degree from La Trobe University, a graduate degree from La Trobe University and an MBA from Melbourne Business School.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 04/05/2026 | 8.184.493 ( 0,68% ) | 351 933 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| PERCHERON THERAPEUTICS LIMITED | Amministratore Delegato | 05/10/2026 |
Bioscience Managers Pty Ltd.
 Bioscience Managers Pty Ltd. Investment ManagersFinance Bioscience Managers invests in both public and private companies located in Asia, Australia and New Zealand. The firm focuses on healthcare and life sciences sectors. It participates in early and growth stage capital transactions. | Analista di Private Equity | 01/11/2017 |
Radiopharm Theranostics (USA), Inc.
 Radiopharm Theranostics (USA), Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical products for diagnostic and therapeutic uses | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| AROVELLA THERAPEUTICS LIMITED | Amministratore Delegato | 04/05/2026 |
| RADIOPHARM THERANOSTICS LIMITED | Direttore/Membro del Consiglio | 26/03/2024 |
| HEXIMA LIMITED | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
Percheron Therapeutics Ltd.
 Percheron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes antisense pharmaceuticals | Health Technology |
Melbourne Business School
 Melbourne Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hexima Ltd.
 Hexima Ltd. BiotechnologyHealth Technology Engages in research and development of plant-derived proteins for treatment of fungal nail infections and provides commercial property services | Health Technology |
Arovella Therapeutics Ltd.
 Arovella Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and distributes medical devices and consumables | Health Technology |
LaTrobe University
 LaTrobe University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bioscience Managers Pty Ltd.
Bioscience Managers Pty Ltd. Investment ManagersFinance Bioscience Managers invests in both public and private companies located in Asia, Australia and New Zealand. The firm focuses on healthcare and life sciences sectors. It participates in early and growth stage capital transactions. | Finance |
Radiopharm Theranostics Ltd.
 Radiopharm Theranostics Ltd. Medical/Nursing ServicesHealth Services Provides nuclear diagnostic services | Health Services |
Radiopharm Theranostics (USA), Inc.
Radiopharm Theranostics (USA), Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical products for diagnostic and therapeutic uses | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
